Promote Sponsor
verified SJR 0,978 · Q1 • database Scopus / SJR & Web of Science indexed
Clinical Therapeutics
United States · Elsevier Inc.
workspace_premium Q1 — Pharmacology lock Subscription Unclaimed

Clinical Therapeutics

Clinical Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 153. It has an SJR impact factor of 0,978 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,978.

Clinical Therapeutics focuses its scope in these topics and keywords: healthy, patients, pharmacokinetics, review, treatment, chinese, administered, drug, combination, gastrointestinal, ...

ISSN: 0149-2918
Editorial: Elsevier Inc.
Category: Pharmacology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,978 Q1
H-index 153
Tasa de Aceptación pie_chart
22% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,978

H-index

153

Docs (year)

202

Docs 3y

561

Total refs

6978

Cites 3y

1709

Citable 3y

470

Cites/Doc 2y

3.02

Ref/Doc

34.54

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe

View more

Viscosupplementation with Hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee

View more

Disease management contracting: legal issues

View more

Compliance of pediatric patients with treatment involving antibiotic suspensions: A pilot study

View more

Comparative study of the analgesic efficacy of flurbiprofen and diclofenac in patients following excimer laser photorefractive keratectomy

View more

Comparative bioavailability of ceftibuten in capsule and suspension forms

View more

Combined metformin and insulin therapy for patients with type 2 diabetes mellitus

View more

Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain

View more

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia

View more

Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

View more

Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone

View more

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

View more
SHOW MORE ARTICLES

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension

View more

A cost-of-illness study of lyme disease in the United States

View more

Assessing the input costs of disease management programs

View more

An outpatient prescription-medication benefit in medicare: So much time, so little consensus

View more

An immunophilin-binding assay for sirolimus

View more

An estradiol matrix transdermal system for the prevention of postmenopausal bone loss

View more

Amlodipine, felodipine, and isradipine in the treatment of chinese patients with mild-to-moderate hypertension

View more

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients

View more

A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy

View more

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients

View more

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

View more

A disease management case study on asthma

View more

FAQS